Philipp Schommers

11PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityRegenerative medicine (incl. stem cells)Gene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma.

Marie Anne-Catherine Neumann, Jessica Schneider, Max Szameitat

|Feb 03, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

|Dec 01, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.

Christian Gaebler, Samad Kor, Kristina Allers

|Oct 06, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

|Oct 14, 2024
Therapeutic interfering particles against HIV: molecular parasites reducing viremia.

Henning Gruell, Stanley Odidika, Philipp Schommers

|Mar 19, 2024
Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.

Pascal von Maltitz, Lukas Wettstein, Tatjana Weil

Pageof 2

Frequent Collaborators

7 joint publications

Henning Gruell

7 joint publications

Florian Klein

4 joint publications

Christoph Kreer

3 joint publications

Arne Kroidl